| __timestamp | Amphastar Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 24419536 |
| Thursday, January 1, 2015 | 46974000 | 34718089 |
| Friday, January 1, 2016 | 47298000 | 40998209 |
| Sunday, January 1, 2017 | 50918000 | 32022880 |
| Monday, January 1, 2018 | 58044000 | 19110051 |
| Tuesday, January 1, 2019 | 63109000 | 26556257 |
| Wednesday, January 1, 2020 | 65157000 | 52275890 |
| Friday, January 1, 2021 | 68920000 | 80981000 |
| Saturday, January 1, 2022 | 66592000 | 124431000 |
| Sunday, January 1, 2023 | 80393000 | 90932000 |
| Monday, January 1, 2024 | 98761000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting strategies in this area.
From 2014 to 2023, Amphastar's SG&A expenses grew steadily, peaking at approximately $80 million in 2023, reflecting a 99% increase from 2014. In contrast, Arrowhead's expenses surged dramatically, especially between 2020 and 2022, with a 138% increase, reaching a high of $124 million in 2022. This spike suggests aggressive investment in growth and expansion.
While Amphastar's consistent growth indicates a stable approach, Arrowhead's fluctuating expenses highlight a more dynamic strategy. The absence of data for Amphastar in 2024 suggests potential changes in their financial reporting or strategy. As these companies navigate the future, their ability to optimize SG&A costs will be pivotal in sustaining competitive advantage.
Selling, General, and Administrative Costs: AbbVie Inc. vs Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.
Ascendis Pharma A/S and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
ADMA Biologics, Inc. vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Apellis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Rhythm Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Perrigo Company plc or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs Dynavax Technologies Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.